With supplier issue now resolved, the Minnesota-run medtech company expects to “reach and then exceed” market growth in the ...

Medtronic — the world's largest medical device company — is preparing for potential new import taxes and other policy changes ...

CEO Geoff Martha said the business did not meet internal growth expectations last quarter due to third-party supply issues ...

Abbott’s Amulet IDE trial put its left atrial appendage closure device up against the Watchman 2.5, which was approved by the ...

Medtronic has reported revenue gains across several of its medical device franchises, leading the company to ... aortic valve ...

Boston Scientific announces favorable OPTION trial results for its WATCHMAN FLX LAAC device. In terms of stroke risk reduction, WATCHMAN FLX is found to be superior to OAC therapy.